ROSH-HA`AYIN, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a global leader in sustainable, on-demand, digital fashion and textile production, announced today that the Company will participate in the 2026 Cantor Global Technology & Industrial Growth Conference and host one-on-one investor meetings. Kornit’s Chief Capital Markets Officer, Andrew G. Backman ("Andy"), will be available for one-on-one investor meetings on Tuesday, March 10, and Wednesd ...

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” or the “Company”), today announced management will participate in a fireside chat and hold one-on-one meetings at the 2026 Leerink Global Healthcare Conference taking place March 8-11 in Miami, Florida. Fireside Date: Tuesday, March 10Time: 3:00pm ESTWebcast: Linked here and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to d ...

Core Insights - Kratos Defense & Security Solutions has successfully completed the Critical Design Review (CDR) for the Advanced Fire Control Ground Infrastructure (AFCGI) system, allowing the program to proceed on an accelerated schedule aligned with launch dates [1][3] - The CDR was completed only eight months after the Preliminary Design Review, demonstrating Kratos' capability to advance complex systems rapidly [2] - The AFCGI program, awarded a $116.7 million contract in 2024, integrates advanced software and resilient ground systems into a unified cloud architecture for real-time fire control missions [3] Company Overview - Kratos is a technology company focused on defense, national security, and commercial markets, known for its innovative and cost-effective solutions [5] - The company emphasizes rapid development and production of systems that meet mission-critical needs, utilizing proven technologies to reduce costs and risks [5] - Kratos aims to be a prime contractor for programs where the probability of winning is high and investments are manageable, while also considering partnerships with larger system integrators when necessary [5]

CHINO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced it will release its 2025 fourth quarter and full year financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call on the same day. Call Date:Thursday, March 12, 2026Time:2:00 p.m. PT/5:00 p.m. ETPhone:877-41 ...

SAN MATEO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) today announced that its Board of Directors authorized a stock repurchase program of up to $400 million of the company’s outstanding Class A common stock. "This follow-on share repurchase program demonstrates our confidence in the Company's long-term strategy, durable growth and dedication to disciplined capital allocation," stated Dennis Woodside, CEO & President. "In addition to achieving GAAP profitability in 2025, we gen ...

ALBANY, Wyo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Buyer Group International, Inc. (OTCID: BYRG) (“BYRG” or the “Company”) is pleased to provide shareholders with a comprehensive update covering metallurgical advancements and recent permitting developments across its Wyoming project portfolio. Big Blue Collaboration Leads Expanded Metallurgical Evaluation Following Early Rhodium Signal and Positive Hazen Results Buyer Group International is pleased to provide additional detail on its metallurgical collaboratio ...

SEATTLE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights Continued progress was made in processing and analyzing Tau proteoform samples from collaborators to support platform validation and expanding scientific publications. Externally generated Tau data m ...

TEL AVIV, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the Leerink Partners Global Healthcare Conference 2026, details as below. Leerink Partners Global Healthcare Conference 2026 (Fireside Chat and 1x1 Meetings) Date and Time: March 11, 2026 at 10:40 a.m. Easte ...

VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its drone subsidiary ZenaDrone has initiated the development of a quantum navigation system designed to enable secure drone operations in GPS-denied and satellite-compromised environments. The system will in ...

Core Insights - Vericel Corporation reported total revenue of $276.3 million for the year ended December 31, 2025, representing a 16% increase compared to $237.2 million in 2024 [12] - The company achieved a net income of $16.5 million, a significant growth of 59% from $10.4 million in the previous year [15] - For the fourth quarter of 2025, total revenue increased by 23% to $92.9 million, with MACI revenue growing by 23% to $84.1 million [8][6] Financial Highlights - Fourth quarter gross margin reached a record 79%, while adjusted EBITDA margin was 40% [9][11] - Full-year gross profit was $205.6 million, or 74% of net revenue, compared to 73% in 2024 [13] - Total operating expenses for the year were $194.6 million, up from $167.6 million in 2024, primarily due to increased headcount and costs associated with a new facility [14] Business Developments - The company completed a MACI sales force expansion and initiated the MACI Ankle™ MASCOT clinical study [6] - Vericel is on track to begin MACI commercial manufacturing in a new facility in 2026 and plans to submit a MACI marketing authorization application to the U.K. MHRA in 2026 [6] - The fourth quarter saw the highest number of MACI implants and surgeons involved since the product's launch [6] Future Guidance - For 2026, Vericel expects total revenue between $316 million and $326 million, with MACI revenue projected to be between $280 million and $286 million [7]